Compare · HCAT vs NBIS
HCAT vs NBIS
Side-by-side comparison of Health Catalyst Inc (HCAT) and Nebius Group N.V. (NBIS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HCAT and NBIS operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- NBIS is the larger of the two at $51.22B, about 378.1x HCAT ($135.5M).
- Over the past year, HCAT is down 43.2% and NBIS is up 45.9% - NBIS leads by 89.0 points.
- NBIS has been more active in the news (18 items in the past 4 weeks vs 2 for HCAT).
- HCAT has more recent analyst coverage (25 ratings vs 23 for NBIS).
PerformanceHCAT-43.19%NBIS+45.86%
2025-10-17+0.00%2026-10-16
- Company
- Health Catalyst Inc
- Nebius Group N.V.
- Price
- $1.73-4.42%
- $165.50-12.16%
- Market cap
- $135.5M
- $51.22B
- 1M return
- -3.89%
- -24.05%
- 1Y return
- -43.19%
- +45.86%
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- 2011
- News (4w)
- 2
- 18
- Recent ratings
- 25
- 23
HCAT
Health Catalyst Inc
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.
Latest HCAT
- SEC Form 4 filed by Health Catalyst Inc
- SEC Form 3 filed by Health Catalyst Inc
- Chief Executive Officer Kohl Simeon was granted 2,747,385 shares and bought $105,439 worth of shares (59,000 units at $1.79), increasing direct ownership by 5,613% to 2,856,385 units (SEC Form 4)
- New insider Kohl Simeon claimed ownership of 25,000 shares (SEC Form 3)
- Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- SEC Form S-8 filed by Health Catalyst Inc
- Health Catalyst Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
- CEO Albert Benjamin covered exercise/tax liability with 35,244 shares, decreasing direct ownership by 2% to 1,388,406 units (SEC Form 4) to satisfy tax liability
- Amendment: SEC Form SCHEDULE 13D/A filed by Health Catalyst Inc
Latest NBIS
- SEC Form 4 filed by Nebius Group N.V.
- SEC Form 4 filed by Nebius Group N.V.
- Rosenblatt initiated coverage on Nebius Group N.V. with a new price target
- Amendment: SEC Form SCHEDULE 13G/A filed by Nebius Group N.V.
- SEC Form 4 filed by Nebius Group N.V.
- Chief Infrastructure Officer Korolenko Andrey sold $6,811,714 worth of Class A Shares (29,090 units at $234.16), decreasing direct ownership by 5% to 522,248 units (SEC Form 4) (for tax liability)
- Chief Technology Officer Shtan Danila sold $3,406,091 worth of Class A Shares (14,546 units at $234.16), decreasing direct ownership by 5% to 260,217 units (SEC Form 4) (withholding tax)
- CEO Volozh Arkadiy sold $8,846,096 worth of Class A Shares (37,778 units at $234.16), decreasing direct ownership by 5% to 785,236 units (SEC Form 4) to cover withholding tax
- AIB Data Centers to Present and Host One-on-One Meetings at the LD Micro 20th Annual Main Event on Wednesday, October 21, 2026
- SEC Form 6-K filed by Nebius Group N.V.